Pharmaceutical Business News Set Back for Pancreatic Cancer: CARRIE study did not meet primary or secondary endpoints By Staff Reports 8 months ago Merrimack Pharmaceuticals, Inc., a clinical-stage oncology company focused on biomarker-defined cancers, today announced top-line results
Pharmaceutical Business News Merck’s Keytruda helps lung cancer patients live longer in trial By Staff Reports 10 months ago Merck & Co’s blockbuster drug Keytruda helped previously untreated lung cancer patients live longer in
Biotechnology cancer Cancer Discovery Uncategorized Identifying a New Therapeutic Target for the Most Common Type of Lung Cancer By Staff Reports 10 months ago Research by Rutgers Cancer Institute of New Jersey investigators has identified novel functions of the
cancer Research suggests possible new treatment for EGFR-positive lung cancer By Staff Reports 2 years ago Findings from a phase III clinical trial point to a potential new treatment for patients
cancer Cancer Discovery Researchers inhibit tumor growth in new subtype of lung cancer By Staff Reports 3 years ago Lung cancer is the most common cause of cancer deaths, accounting for about a third